The year 2024 marks a challenging period for the Turkish healthcare industry. Economic fluctuations, inflation and increases in exchange rates have put a strain on supply chains in the life sciences sector, prompting various pharmaceutical and medical device companies to reassess their market strategies. During this process, the decisions of certain companies to suspend their plans to launch new products, in addition to issues related to access to medication, have fuelled the already present uncertainties in the industry.
Meanwhile, Türkiye's healthcare regulations have largely become aligned with international standards and have progressively evolved into a stronger structure. The Ministry of Health and the Turkish Medicines and Medical Devices Agency ("Agency") continue to implement new measures to ensure product safety and eliminate uncertainties in the regulations relevant for the sector. Developments in areas such as marketing authorisations, registration systems, and codes of conduct have contributed to creating a more transparent and reliable foundation for the sector.
In addition, the 12th Development Plan 2024 – 2028 ("Development Plan") and the 2025 Annual Presidential Program define Türkiye's development goals and strategic policies for various sectors. These documents focus on enhancing sustainability in Türkiye's healthcare sector, improving domestic production capacity, and reducing dependence on imports. Supporting domestic production, increasing the effectiveness of healthcare services, and promoting innovative technologies are the key components of these objectives.
In this light, a significant transformation process is anticipated in the Turkish healthcare sector, with the hope that it will make a substantial contribution to economic development.
CONTENTS
- Medicines and Medical Devices Sectors: Current Status and Evolving Dynamics Gün + Partners , Articles , Feb 25, 2025
- Market Availability of Products and Parallel Trade Gün + Partners , Articles , Feb 25, 2025
- Named Patient Program Gün + Partners , Articles , Feb 25, 2025
- Developments in the Field of Medical Devices Gün + Partners , Articles , Feb 25, 2025
- Use of Hemp in Production of Pharmaceuticals Gün + Partners , Articles , Feb 25, 2025
- Food Supplements Gün + Partners , Articles , Feb 25, 2025
- Interactions with Health Care Professionals, Transfer of Values and Conditions of Payment Gün + Partners , Articles , Feb 25, 2025
- Market Access - Alternative Reimbursement Models Gün + Partners , Articles , Feb 25, 2025
- Fixed Exchange Rate in Pricing of Pharmaceuticals and its Impact Gün + Partners , Articles , Feb 25, 2025
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.
